As of 2025-12-14, the Relative Valuation of Immunovant Inc (IMVT) is (61.95) USD. This relative valuation is based on P/E multiples. With the latest stock price at 26.42 USD, the upside of Immunovant Inc based on Relative Valuation is -334.5%.
The range of the Relative Valuation is (45.59) - (64.67) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.0x - 24.4x | 20.7x |
| Forward P/E multiples | 17.2x - 34.9x | 26.0x |
| Fair Price | (45.59) - (64.67) | (61.95) |
| Upside | -272.5% - -344.8% | -334.5% |
| Date | P/E |
| 2025-12-10 | -8.60 |
| 2025-12-09 | -8.59 |
| 2025-12-08 | -8.74 |
| 2025-12-05 | -8.62 |
| 2025-12-04 | -8.64 |
| 2025-12-03 | -8.57 |
| 2025-12-02 | -8.31 |
| 2025-12-01 | -8.58 |
| 2025-11-28 | -9.11 |
| 2025-11-26 | -8.94 |
| 2025-11-25 | -9.04 |
| 2025-11-24 | -8.80 |
| 2025-11-21 | -8.52 |
| 2025-11-20 | -8.60 |
| 2025-11-19 | -8.74 |
| 2025-11-18 | -8.94 |
| 2025-11-17 | -9.17 |
| 2025-11-14 | -8.96 |
| 2025-11-13 | -8.61 |
| 2025-11-12 | -8.84 |
| 2025-11-11 | -8.64 |
| 2025-11-10 | -8.82 |
| 2025-11-07 | -8.81 |
| 2025-11-06 | -8.93 |
| 2025-11-05 | -8.90 |
| 2025-11-04 | -9.13 |
| 2025-11-03 | -8.97 |
| 2025-10-31 | -9.31 |
| 2025-10-30 | -9.36 |
| 2025-10-29 | -8.17 |
| 2025-10-28 | -8.29 |
| 2025-10-27 | -8.09 |
| 2025-10-24 | -7.15 |
| 2025-10-23 | -7.07 |
| 2025-10-22 | -7.13 |
| 2025-10-21 | -7.26 |
| 2025-10-20 | -7.25 |
| 2025-10-17 | -6.61 |
| 2025-10-16 | -6.57 |
| 2025-10-15 | -6.76 |
| 2025-10-14 | -6.60 |
| 2025-10-13 | -6.55 |
| 2025-10-10 | -6.43 |
| 2025-10-09 | -6.60 |
| 2025-10-08 | -6.07 |
| 2025-10-07 | -6.08 |
| 2025-10-06 | -6.24 |
| 2025-10-03 | -6.38 |
| 2025-10-02 | -6.31 |
| 2025-10-01 | -6.17 |